Paper · 35809752

ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group.

Pascual J and 19 others. Ann Oncol, 2022. Cited by 636 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group. Papers, record 35809752. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35809752

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group.; PubMed
Journal: Ann Oncol; PubMed
Year: 2022; PubMed
Publication types: Journal Article, Research Support, Non-U.S. Gov't; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/35809752/; PubMed
DOI: https://doi.org/10.1016/j.annonc.2022.05.520; PubMed
The journal: https://conductscience.org/library/journal-index/9007735; PubMed
Citations, by iCite: 636; iCite
Relative citation ratio, by iCite: 45.6; iCite
Revised in PubMed: 2026-07-26; PubMed

Authors20

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Pascual J	J
2	Attard G	G
3	Bidard FC	F-C
4	Curigliano G	G
5	De Mattos-Arruda L	L
6	Diehn M	M
7	Italiano A	A
8	Lindberg J	J
9	Merker JD	J D
10	Montagut C	C

1 to 10 of 20Source PubMed

See all 20 authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Circulating Tumor DNA	Major topic
Biomarkers, Tumor
Humans
Mutation
Neoplasm Recurrence, Local
Precision Medicine

Source PubMed

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes it	Agency	Country	NIH project	Stated by	Source
R01 CA244526	NCI NIH HHS	United States	R01CA244526	PubMed	NIH RePORTER
R01 CA254179	NCI NIH HHS	United States	R01CA254179	PubMed	NIH RePORTER
R01 CA257655	NCI NIH HHS	United States	R01CA257655	PubMed	NIH RePORTER

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

Trial	Title	The trial lists it as	Named in the paper's record	Source
NCT06710093	Power of Liquid Biopsy Tracking in Immunotherapy Treated Stage IV Melanoma	Background		ClinicalTrials.gov
NCT07597252	ctDNA Monitoring After Pancreatic Cancer Surgery (K-4CARE Lite Study)	Background		ClinicalTrials.gov

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by494

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 636 citations.

PMID	Title	Journal	Year	In Papers	Source
42,985,389	Overcoming the Shield: Mechanisms of Resistance to DNA Repair Inhibitors and Strategies to Restore Synthetic Lethality.	Oncol Res	2026	https://conductscience.org/library/papers/42985389	PubMed
42,974,638	Artificial intelligence assisted genomic profiling of ovarian cancer liver metastases.	Front Genet	2026	https://conductscience.org/library/papers/42974638	PubMed
42,974,481	Artificial Intelligence-Enabled Nanomedicine in Precision Oncology: Diagnosis, Targeted Therapy, and Clinical Translation.	Int J Nanomedicine	2026	https://conductscience.org/library/papers/42974481	PubMed
42,973,950	Nationwide real-world data on tumor-agnostic genomic companion diagnostics and comprehensive genomic profiling tests.	Mol Clin Oncol	2026	https://conductscience.org/library/papers/42973950	PubMed
42,964,788	Consensus and controversy of liquid biopsy using circulating tumour DNA (ctDNA) for molecular residual disease detection in colorectal cancer.	Lancet Reg Health West Pac	2026	https://conductscience.org/library/papers/42964788	PubMed
42,964,697	Endocrine resistance in HR+/HER2- breast cancer: molecular mechanisms and emerging therapeutic strategies.	Front Oncol	2026	https://conductscience.org/library/papers/42964697	PubMed
42,958,365	Dynamic ctDNA-MRD in breast cancer: subtype-specific implications for perioperative decision-making, postoperative surveillance, and MRD-guided therapy.	World J Surg Oncol	2026	https://conductscience.org/library/papers/42958365	PubMed
42,955,557	Comparative analysis of ctDNA-MRD and MVI in predicting postoperative recurrence of hepatocellular carcinoma: a prospective multicenter cohort study.	Hepatol Int	2026	https://conductscience.org/library/papers/42955557	PubMed
42,955,439	Treatment options after tumor resistance: exploiting vulnerabilities from genome to tumor microenvironment.	Cancer Metastasis Rev	2026	https://conductscience.org/library/papers/42955439	PubMed
42,953,478	Cellular origins and evolutionary dynamics of plasma cfDNA in solid tumors: integrating germline, tumor-derived, and hematopoietic variation for MRD and treatment guidance.	Front Cell Dev Biol	2026	https://conductscience.org/library/papers/42953478	PubMed

1 to 10 of 494

See all 494 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35809752

GET https://conductscience.org/api/papers/v1/35809752/cited_by?page=2

API reference For AI assistants